17 18 19 2 CRISPR-Cas9 is a powerful technology that has enabled genome editing in a wide 20 range of species. However, the currently developed Cas9 homologs all originate 21 from mesophilic bacteria, making them susceptible to proteolytic degradation and 22 unsuitable for applications requiring function at elevated temperatures. Here, we 23 show that the Cas9 protein from the thermophilic bacterium Geobacillus 24 stearothermophilus (GeoCas9) catalyzes RNA-guided DNA cleavage over a wide 25 temperature range and has an enhanced protein lifetime in human plasma.
6 this region to escape cleavage by Cas9 25 . To identify the PAM for GeoCas9, we first 115 searched for naturally targeted viral and plasmid sequences using CRISPRtarget 26 . The 116 three sequenced strains of G. st. provided 77 spacer sequences, and 3 of them had 117 high-confidence viral and plasmid targets ( Supplementary Fig. 2 , Supplementary Table   118 3,). Extracting the sequences 3′ of the targeted sequence revealed a consensus of 5′-119 NNNNCNAA-3′ ( Fig. 2a, ED Fig. 2 ). Given the low number of viral targets, we next 120 performed cleavage assays on substrates containing various PAM sequences, revealing 121 a complete PAM sequence of 5′-NNNNCRAA-3′ (Fig. 2b) .
122
In addition to the CRISPR loci found in G. st. strains, we also found a type II 123 CRISPR locus in Geobacillus LC300 containing a Cas9 with ~97% amino acid identity to 124 the G. st. Cas9. Despite having nearly identical sequences, alignment of these two 125 homologs of GeoCas9 revealed a tight cluster of mutations in the PAM interacting 126 domain (PI). Furthermore, mapping these mutations onto the homology model of 127 GeoCas9 showed that they are located near the PAM region of the target DNA ( Fig. 2c,   128 d). We hypothesized that this GeoCas9 variant might have evolved altered PAM 129 specificity. By searching for viral targets using the spacers in the G. LC300 array, we 130 identified a preference for GMAA in place of the CRAA PAM of G. st., lending support to 7 GeoCas9 without resorting to structure based protein engineering as has been done for 140 other Cas9 homologs 27 .
142
Identification of both crRNA and tracrRNA and engineering of GeoCas9 sgRNA 143 CRISPR-Cas9 systems use a trans-activating crRNA (tracrRNA), which is 144 required for maturation of the crRNA and activation of Cas9 6,28 . To identify the tracrRNA 145 for GeoCas9, we cultured G. st. and deep sequenced the small RNA it produced. We 146 found that the CRISPR array was transcribed despite a lack of phage or plasmid 147 challenge, and that the array was transcribed in the opposite direction of the Cas 148 proteins (Fig. 3a) . The crRNA was processed to 23nt (Fig. 3b ) of the spacer sequence 149 and 18nt of the repeat sequence in vivo, similar to other small type IIC Cas9 proteins 8, 29 .
150
Mapping of the RNAseq reads to the CRISPR array also revealed a putative tracrRNA 151 upstream of the Cas9 open reading frame (ORF).
152
We joined this putative tracrRNA to the processed crRNA using a GAAA-153 tetraloop to generate a single-guide RNA (sgRNA) 30 . Variations of this sgRNA were in 154 vitro transcribed and tested for their ability to direct GeoCas9 to cleave a radiolabeled 155 double-stranded DNA target at 37°C. We first varied the length of the crRNA:tracrRNA 156 duplex and found that this modification had little impact on the DNA cleavage rate (left 157 panel, Fig. 3c ), making it a valuable place for further sgRNA modifications 31 . Next, we 158 tested the length of the tracrRNA, choosing stopping points near predicted rho-159 independent terminators. In contrast to the crRNA:tracrRNA duplex length, the length of 160 the tracrRNA had a dramatic effect on the cleavage rate, with sequences shorter than 161 91nt supporting only a small amount of cleavage (middle panel, Fig. 3c ). Finally, we 162 varied the length of the spacer sequence and found that 21-22nt resulted in a more than 163 5-fold increase in cleavage rate, compared to the 20nt spacer preferred by SpyCas9
164
(right panel, Fig. 3c ). This finding contrasts with the most abundant spacer length of 23nt 165 8 found by RNAseq. This difference may be due to inter-or intramolecular guide 166 interactions in the in vitro transcribed sgRNA 32 .
168

Genome editing by GeoCas9 RNPs in mammalian cells
169
With evidence that GeoCas9 maintains cleavage activity at mesophilic 170 temperatures, we assessed the ability of GeoCas9 to edit mammalian genomes. We 171 compared GeoCas9 and SpyCas9 editing efficiency by delivering preassembled 172 ribonucleoprotein complexes (RNPs) into cultured cells, circumventing differences 173 between SpyCas9 and GeoCas9 protein expression. First, GeoCas9 RNPs targeting 174 regions adjacent to various PAM sequences were delivered into HEK293T cells 175 expressing a destabilized GFP ( Fig. 4a ). We found that when targeted to sequences 176 adjacent to the preferred CRAA PAM, GeoCas9 decreased GFP fluorescence at levels 177 comparable to those observed for SpyCas9 ( Fig. 4a ). Next, we targeted GeoCas9 to 178 cleave the native genomic loci DNMT1 and AAVS1 (Fig. 4b,c ). We varied the length of 179 the targeting spacer sequence and found that at one site 21nt was a sufficient length to 180 efficiently induce indels while at another site a 22nt spacer length was necessary. Given 181 this variability and that extending the spacer length to 22nt had no detrimental effects, 182 we conclude that a 22nt guide segment length is preferred for use in genome editing 183 applications. Moreover, when we tested editing efficiency at a site containing an 184 overlapping PAM for both GeoCas9 and SpyCas9, we observed similar editing 185 efficiencies by both proteins (Fig. 4b ). At the DNMT1 locus we titrated amounts of (Fig. 1d , e), we tested whether the GeoCas9 RNP maintains 195 activity after exposure to high temperatures. We incubated SpyCas9 and GeoCas9 at a 196 challenge temperature and added equimolar substrate to test the fraction of RNP that 197 remained functional. After incubation for 10 min at 45°C, the fraction of active SpyCas9 198 was greatly reduced (Fig. 5a ). In contrast, the fraction of GeoCas9 after incubation at 199 45°C remained at 100% and not until challenge at 70°C did we detect a decrease in 200 activity ( Fig. 5a ).
201
Often thermostability comes at the cost of reduced activity at lower 202 temperatures 33 . However, the wide range of natural growth temperatures for G. st.
203
suggested that GeoCas9 might maintain activity at mesophilic temperatures. To examine 204 this hypothesis, we measured the cleavage rate of SpyCas9 and GeoCas9 at various 205 temperatures ( Fig. 5b ). SpyCas9 DNA cleavage rates increased between 20-35°C, 206 reaching maximum levels from 35-45°C. Above these temperatures, SpyCas9 activity 207 dropped sharply to undetectable levels, as predicted by thermostability measurements.
208
In contrast, GeoCas9 activity increased to a maximum measured value at 50°C and 209 maintained maximum detectable activity up to 70°C, dropping to low levels at 75°C.
210
These results make GeoCas9 a valuable candidate for editing obligate thermophilic 211 organisms and for biochemical cleavage applications requiring Cas9 to operate at 212 elevated temperatures.
213
It was shown previously that thermostable proteins have longer lifetime in 214 blood 34 . To test if this is the case for GeoCas9, we incubated SpyCas9 and GeoCas9 in 215 diluted human plasma at 37°C for 8 hrs and measured the amount of Cas9 activity 216 remaining ( Fig. 5c ). Although SpyCas9 maintained activity when incubated in reaction 217 10 buffer at 37°C, its activity was abolished even at the lowest concentration of plasma. In 218 contrast, GeoCas9 maintained robust activity after incubation with human plasma, 219 making it a promising candidate for in vivo RNP delivery.
221
Discussion
222
Our results establish GeoCas9 as a thermostable Cas9 homolog and expand the 223 temperatures at which Cas9 can be used. We anticipate that the development of 224 GeoCas9 will enhance the utility of CRISPR-Cas9 technology at both mesophilic and 225 thermophilic temperatures. The ability of Cas9 to function reliably in a wide range of 226 species has been key to its rapid adoption as a technology, but the previously developed 227 Cas9 homologs are limited for use in organisms that can grow below 42°C. The 228 complementary temperature range of GeoCas9 with SpyCas9 ( Fig. 5c ) opens up Cas9-229 based genome editing to obligate thermophiles and facultative thermophiles, without the 230 additional steps of altering the temperature of the organisms. We also anticipate that 231 GeoCas9 will be useful for in vitro molecular biology applications requiring targeted 232 cleavage at elevated temperatures. Furthermore, we predict that the extended lifetime 233 of GeoCas9 in human plasma may enable more efficient delivery of Cas9 RNPs.
234
We were interested to note that GeoCas9 and SpyCas9 induced similar levels of 235 indels in HEK293T cells as SpyCas9 when delivered as an RNPs (Fig. 4b-d 
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406
For thermostability measurements (Fig. 4a 
415
For thermophilicity measurements (Fig. 4b) , 500nM Cas9 was complexed with 416 750nM sgRNA in 1x Reaction Buffer for 5min at 37°C. The samples were placed at the 417 assayed temperature (20°C-80°C) and 100nM of PCR product was added to the 418 reaction. Time points were quenched using 6× Quench Buffer and analyzed on a 1.25% 419 agarose gel stained with SYBR Safe (Thermo Fisher Scientific).
420
To study the effect of human plasma on the stability of Cas9 proteins,
421
preassembled Cas9-RNP was incubated for 8 hours either at 37°C or 4°C in Reaction
422
Buffer with the specified amount of normal human plasma. Substrate was then added 423 and cleavage products were analyzed as described for thermostability measurements. 
433
Adapters were trimmed using Cutadapt and sequences >10nt were mapped to the G. st.
434
CRISPR locus using Bowtie 2 40 . 
485
The length of the tracrRNA, crRNA:tracrRNA duplex and spacer was optimized Spacer (21nt) tracrRNA (98nt) Repeat ( 
